DCIR/CLEC4A Antibody (9E8) - Azide and BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-09022
Recombinant Monoclonal Antibody. Clone 9E8 was used by HLDA to establish CD designation.
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry
Label
Unconjugated
Antibody Source
Recombinant Monoclonal Mouse IgG1 kappa Clone # 9E8
Format
Azide and BSA Free
Concentration
1 mg/ml
Product Specifications
Immunogen
This antibody was raised by immunising BALB/c mice with a dendritic cell immunoreceptor ectodomain-human Fc fusion protein.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1 kappa
Applications for DCIR/CLEC4A Antibody (9E8) - Azide and BSA Free
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
This antibody has been used in flow cytometric analysis of DCIR expression by peripheral blood mononuclear cells (Klechevsky et al, 2010). A recombinant humanised form of this antibody fused to protein antigens is under investigation as an antigen-targeting vaccine (Flamar et al, 2012), and has been shown to trigger antigen-specific CD8+ T cell immunity.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Format
Azide and BSA Free
Preservative
0.02% Proclin 300
Concentration
1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: DCIR/CLEC4A
Long Name
Dendritic Cell Immunoreceptor
Alternate Names
CD367, CLEC4A, CLECSF6, DDB27, LLIR
Gene Symbol
CLEC4A
Additional DCIR/CLEC4A Products
Product Documents for DCIR/CLEC4A Antibody (9E8) - Azide and BSA Free
Product Specific Notices for DCIR/CLEC4A Antibody (9E8) - Azide and BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...